Bengaluru, January 2026: Biopeak, a health-tech startup focused on AI-driven health optimisation and longevity, has raised $2.7 million in a follow-on funding round led by NKSquared, the investment firm of Nikhil Kamath.
This marks Kamath’s second investment in Biopeak, following an earlier infusion of $1.43 million in August 2024, underscoring continued investor confidence in the startup’s approach to preventive and longevity-focused healthcare.
Expansion Plans and Use of Funds
According to the company, the fresh capital will be deployed to expand operations, including the launch of a new clinic, and to strengthen diagnostic capabilities, proprietary AI tools, research initiatives, and clinical programmes.
Biopeak aims to scale its integrated healthcare model as demand rises for structured, data-driven longevity and performance optimisation services in India.
Building a “Family Health Office” for Longevity
Founded in 2025 by Rishi Pardal and Shiva Subramanian, Biopeak positions itself as a healthspan optimisation platform, offering what it describes as a “family health office” approach. The model focuses on long-term health outcomes rather than episodic treatment, delivering personalised plans for sustained wellbeing and performance.
The platform combines AI-driven molecular diagnostics, advanced imaging, and expert-led programmes to generate actionable insights tailored to individual health profiles.
Advanced Diagnostics and AI-Led Insights
Biopeak integrates a wide range of diagnostic tools, including:
-
Organic acid profiling
-
Microbiome mapping
-
Whole-exome functional genomics
-
Salivary cortisol rhythm analysis
-
Imaging technologies such as MRI, CT, DXA, and ECHO
These diagnostics feed into the company’s AI systems, which help design personalised interventions around nutrition, sleep, stress management, and lifestyle optimisation. Its in-house clinics deliver specialised care based on continuous data analysis and longitudinal tracking.
Targeting High-Performance Individuals
The Bengaluru-based startup primarily targets high achievers, executives, and women, offering programmes that blend specialist medical teams, wearable data, AI insights, and diagnostics tailored to Indian biology and disease patterns.
Biopeak’s model emphasises early risk detection, preventive interventions, and long-term monitoring, with the goal of improving resilience, performance, and overall healthspan.
Growing Demand for Longevity Services
Over the past year, Biopeak says it has seen steady growth in its client base and clinical offerings, reflecting increasing interest in longevity and preventive healthcare among urban professionals.
The company opened its first clinic in Bengaluru last year and plans to launch a second clinic in the coming month, as it looks to deepen its physical presence alongside its technology platform.
As awareness around healthspan and proactive healthcare grows in India, Biopeak is positioning itself at the intersection of AI, advanced diagnostics, and personalised medicine, supported by repeat backing from one of the country’s most prominent tech investors.
Ruchi Kumar is the associate editor at Entrepreneur News Network and TVW News India, where she leads editorial strategy, brand storytelling, and startup ecosystem coverage. With a strong focus on innovation, business, and marketing insights, he curates impactful narratives that spotlight India’s evolving entrepreneurial landscape.